|Articles|March 1, 2018
- BioPharm International-03-01-2018
- Volume 31
- Issue 3
BioPharm International, March 2018 Issue (PDF)
Click the title above to open the BioPharm International March 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
FDA Heightens Drive for Transparencyalmost 8 years ago
Current Challenges in Bioprocesses Developmentalmost 8 years ago
Characterizing a Bioprocess with Advanced Data Analyticsalmost 8 years ago
Computerized Systems Validationalmost 8 years ago
Regulatory Role in Bio/Pharma Progressalmost 8 years ago
Poseidon Takes on the Pharma Supply Chainalmost 8 years ago
Identifying and Controlling CPPs and CMAsalmost 8 years ago
Employing Spectroscopic Tools in Downstream Process Controlalmost 8 years ago
Biologic NMEs Maintain Strong Presence in 2017 Drug ApprovalsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
2
How Mitigation and Maintenance Protect Against Future Risk
3
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
4
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
5
